Northside Capital Management LLC Purchases New Holdings in Intuitive Surgical, Inc. $ISRG

Northside Capital Management LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 1,683 shares of the medical equipment provider’s stock, valued at approximately $669,000.

Several other hedge funds and other institutional investors have also bought and sold shares of ISRG. Main Street Group LTD purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at $30,000. Laurel Wealth Advisors LLC purchased a new position in shares of Intuitive Surgical in the 4th quarter worth about $31,000. Vermillion Wealth Management Inc. boosted its holdings in shares of Intuitive Surgical by 58.1% in the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after buying an additional 25 shares during the last quarter. Turning Point Benefit Group Inc. grew its position in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 50 shares during the period. Finally, Motiv8 Investments LLC bought a new position in Intuitive Surgical during the fourth quarter valued at about $34,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. This trade represents a 6.99% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares in the company, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 7,106 shares of company stock valued at $2,949,518. Company insiders own 0.60% of the company’s stock.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical’s second-quarter results exceeded expectations: revenue rose 18.4% year over year to $2.89 billion, while EPS reached $2.80 versus the $2.48 consensus estimate. Higher margins, continued adoption of its da Vinci and Ion platforms, and long-term demand for robotic-assisted surgery support the bullish case. Intuitive Surgical Just Beat Earnings
• Positive Sentiment: A bullish investor cited Intuitive Surgical’s potential once-per-decade hardware replacement cycle and approximately $8.6 billion cash position, arguing that the more than 30% year-to-date decline could create an attractive long-term entry point. The Number One Reason I Keep Buying Intuitive Surgical
• Neutral Sentiment: Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus and an average price target of $509.02. However, several firms recently lowered their targets, reflecting greater caution after the earnings report.
• Neutral Sentiment: Reported short interest was zero shares, implying no measurable short-selling pressure. The figure appears unusual and may reflect incomplete or unreliable data rather than a meaningful market signal.
• Negative Sentiment: Despite the earnings beat, investors remain concerned about slowing domestic procedure growth and whether the company’s roughly 46 P/E adequately reflects its growth prospects. Those concerns have contributed to the stock’s recent weakness. Intuitive Surgical Earnings and Valuation Analysis
• Negative Sentiment: Director Amy L. Ladd sold 472 shares across August 10–11, reducing her holdings by a substantial percentage, while EVP Gary Loeb sold 400 shares. Both transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their significance as a discretionary bearish signal but may still weigh modestly on sentiment.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $401.23 on Wednesday. The stock has a market capitalization of $141.75 billion, a P/E ratio of 45.96, a P/E/G ratio of 2.84 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The stock’s 50-day simple moving average is $392.47 and its 200 day simple moving average is $443.35.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company earned $1.81 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of a number of research analyst reports. UBS Group initiated coverage on shares of Intuitive Surgical in a report on Tuesday, July 28th. They set a “neutral” rating and a $500.00 price objective for the company. Bank of America dropped their target price on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Wells Fargo & Company restated an “overweight” rating and set a $487.00 price target (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Monday, July 20th. Finally, JPMorgan Chase & Co. dropped their price objective on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research note on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $509.02.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.